HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Fukuda Selected Research

perfluorobutane (AI 700)

1/2020Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
10/2015Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
1/2014Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
9/2013Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
10/2012Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
8/2010Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Fukuda Research Topics

Disease

32Hepatocellular Carcinoma (Hepatoma)
10/2021 - 04/2002
20Neoplasms (Cancer)
10/2021 - 01/2002
5Stroke (Strokes)
01/2022 - 04/2006
4Carcinogenesis
01/2023 - 02/2002
4Liver Diseases (Liver Disease)
07/2019 - 01/2003
3Infections
01/2023 - 03/2021
3Paralysis (Palsy)
01/2022 - 01/2006
3Fibrosis (Cirrhosis)
03/2021 - 01/2003
3Neoplasm Metastasis (Metastasis)
06/2020 - 03/2008
3Rheumatoid Arthritis
10/2016 - 05/2004
2Liver Neoplasms (Liver Cancer)
10/2021 - 01/2021
2Chronic Hepatitis C
03/2021 - 09/2013
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2021 - 04/2002
2Chromosomal Instability (Chromosome Stability)
12/2020 - 12/2018
2Thrombosis (Thrombus)
06/2020 - 01/2017
2Necrosis
08/2014 - 11/2005
2Vomiting
01/2010 - 02/2005
2Osteoarthritis
03/2006 - 05/2004
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2006 - 05/2004
2Alzheimer Disease (Alzheimer's Disease)
12/2004 - 11/2002
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2003 - 04/2002
1Body Weight (Weight, Body)
05/2024
1Adenocarcinoma
04/2024
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Thrombocytopenia (Thrombopenia)
06/2020
1Hyperthyroidism
06/2020
1Fever (Fevers)
06/2020
1Enteritis
03/2020
1Anemia
03/2020
1Hypesthesia (Numbness)
03/2020
1Pituitary Neoplasms (Pituitary Adenoma)
09/2019
1Type 2 Diabetes Mellitus (MODY)
09/2019
1Cerebral Infarction
07/2019
1Genomic Instability
12/2018
1Lung Neoplasms (Lung Cancer)
12/2018
1Colonic Neoplasms (Colon Cancer)
12/2018
1Hemiplegia (Spastic Hemiplegia)
02/2017
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2016
1Autoimmune Diseases (Autoimmune Disease)
10/2016

Drug/Important Bio-Agent (IBA)

7CopperIBA
07/2005 - 01/2002
6Sorafenib (BAY 43-9006)FDA Link
07/2020 - 08/2014
6Contrast MediaIBA
01/2020 - 08/2010
6perfluorobutane (AI 700)IBA
01/2020 - 08/2010
5Proteins (Proteins, Gene)FDA Link
09/2019 - 05/2004
4MetallothioneinIBA
03/2006 - 04/2002
4ZincIBA
07/2005 - 04/2002
3Pentetic Acid (DTPA)FDA LinkGeneric
01/2021 - 07/2018
3GadoliniumIBA
01/2021 - 07/2018
3Ethanol (Ethyl Alcohol)IBA
08/2011 - 06/2004
3AutoantibodiesIBA
03/2007 - 05/2004
3ajoeneIBA
04/2006 - 10/2002
2Antiviral Agents (Antivirals)IBA
01/2023 - 03/2021
2Type A Botulinum Toxins (Botox)FDA Link
01/2022 - 02/2017
2Transfer RNA (tRNA)IBA
11/2021 - 09/2019
2Doublecortin-Like KinasesIBA
12/2020 - 12/2018
2Therapeutic UsesIBA
07/2020 - 06/2020
2lenvatinibIBA
06/2020 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2019
2Hormones (Hormone)IBA
09/2019 - 02/2005
2Cisplatin (Platino)FDA LinkGeneric
03/2015 - 04/2006
2AntigensIBA
03/2007 - 11/2005
2Superoxide DismutaseIBA
04/2006 - 07/2005
2Immunoglobulin G (IgG)IBA
03/2006 - 05/2004
2Amyloid beta-PeptidesIBA
12/2004 - 11/2002
2Peptides (Polypeptides)IBA
12/2004 - 02/2002
2Amyloid (Amyloid Fibrils)IBA
12/2004 - 11/2002
2MetalsIBA
06/2004 - 01/2003
2IronIBA
06/2004 - 01/2003
1Oxygen (Dioxygen)IBA
05/2024
1Carcinoembryonic AntigenIBA
04/2024
1MethyltransferasesIBA
11/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2021
1SofosbuvirIBA
03/2021
1sofosbuvir drug combination ledipasvirIBA
03/2021
1SonazoidIBA
03/2021
1regorafenibIBA
07/2020
1AlbuminsIBA
06/2020
1BilirubinIBA
06/2020
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
03/2020
1EnzymesIBA
09/2019
1Growth Hormone (Somatotropin)IBA
09/2019
1AnticoagulantsIBA
07/2019
1MicroRNAs (MicroRNA)IBA
07/2019
1Phosphotransferases (Kinase)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
12/2018
1acarboxyprothrombin (PIVKA)IBA
01/2017
1Methotrexate (Mexate)FDA LinkGeneric
10/2016

Therapy/Procedure

13Therapeutics
01/2022 - 06/2004
11Radiofrequency Ablation
10/2021 - 06/2004
4Drug Therapy (Chemotherapy)
03/2020 - 02/2006
3High-Intensity Focused Ultrasound Ablation
12/2013 - 08/2010
2Radiotherapy
03/2021 - 03/2020
2Punctures
01/2018 - 08/2014
2Neoadjuvant Therapy
03/2008 - 04/2006
1Liver Transplantation
10/2021
1Enteral Nutrition (Feeding, Tube)
01/2021
1Esophagectomy
01/2021
1Hysterectomy
03/2020
1Injections
03/2020
1Psychology Biofeedback (Biofeedback)
01/2019